INCR · Intercure Ltd.
Market Cap
$66.47M
Shares
15.00M
Volume · Oct 20
2540
Avg daily vol (40 sessions)
9975
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.43
Open$4.76
Day$4.43–4.76
52W close$0.73–5.95
Avg vol 30d4K
Short int5K · 0.0% float · 1.0d
Short vol52%
Last earningsDec 31, 2022
DataJan 2020–Oct 2026
Up next
Date not confirmed
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+151%
above
Price vs 50-day avg
+1%
above
RSI (14)
39
neutral
MACD trend
Negative
52-week position
71%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−18%
trailing
6-month return
+411%
trailing
YTD return
+387%
this year
Relative strength
+403%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $2 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.03% of float · ▼ -18.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
16 holders — mid 3-yr range
Squeeze score
20
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
595%
annualized · 1-yr
Max drawdown
−54%
past year
ATR
5.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+151%
Bullish
Price vs 50-day avg
+1%
Bullish
RSI (14)
39
Neutral
MACD trend
Negative
Bearish
52-week position
71%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $2 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.03% of float · ▼ -18.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
16 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $4 · 71%
Range high $6
vs 200-day avg +151%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
INCR
this stock
Intercure Ltd.
|
$66.47M | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$62.65B | +28.8% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$48.88B | +2.4% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$48.14B | +30.9% | +4.3% | 67.7 | 2.6% |
|
HLN
Haleon plc
|
$44.72B | +0.6% | — | — | 0.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| INCR | -11.9% | -17.8% | +411.0% | -16.0% | +386.8% |
| SPY | -1.2% | -0.6% | +8.1% | +0.8% | +12.8% |
| vs SPY | -10.8% | -17.3% | +402.9% | -16.8% | +374.0% |